Items where authors include "Himmelmann, A."

Article

Gregersen, I., Michelsen, A.E., Lunde, N.N. et al. (17 more authors) (2020) Legumain in acute coronary syndromes: A substudy of the PLATO (Platelet Inhibition and Patient Outcomes) trial. Journal of the American Heart Association, 9 (17). e016360. ISSN 2047-9980

Sumaya, W., Wallentin, L., James, S.K. et al. (5 more authors) (2020) Impaired fibrinolysis predicts adverse outcome in acute coronary syndrome patients with diabetes: A PLATO sub-study. Thrombosis and Haemostasis, 120 (03). pp. 412-422. ISSN 0340-6245

Åkerblom, A., James, S.K., Lakic, T.G. et al. (9 more authors) (2019) Interleukin‐18 in patients with acute coronary syndromes. Clinical Cardiology, 42 (12). pp. 1202-1209. ISSN 0160-9289

Dellborg, M., Bonaca, M.P., Storey, R.F. orcid.org/0000-0002-6677-6229 et al. (20 more authors) (2019) Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54. European Heart Journal - Cardiovascular Pharmacotherapy, 5 (4). pp. 200-206. ISSN 2055-6837

Åkerblom, A., Wojdyla, D., Steg, P.G. et al. (9 more authors) (2019) Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes : insights from the PLATelet inhibition and patient outcomes (PLATO) trial. Journal of Thrombosis and Thrombolysis, 48 (4). pp. 563-569. ISSN 0929-5305

Franchi, F., James, S.K., Ghukasyan Lakic, T. et al. (10 more authors) (2019) Impact of diabetes Mellitus and Chronic Kidney Disease on cardiovascular outcomes and platelet P2Y12 receptor antagonist effects in patients with acute coronary syndromes: Insights from the PLATO trial. Journal of the American Heart Association, 8 (6). e011139. ISSN 2047-9980

Åstrand, M. orcid.org/0000-0003-2053-3413, Amilon, C., Röshammar, D. et al. (6 more authors) (2019) Pharmacokinetic-pharmacodynamic modelling of platelet response to ticagrelor in stable coronary artery disease and prior myocardial infarction patients. British Journal of Clinical Pharmacology, 85 (2). pp. 413-421. ISSN 0306-5251

Sumaya, W., Wallentin, L., James, S.K. et al. (6 more authors) (2018) Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy. European Heart Journal . ehy013. ISSN 0195-668X

Ueland, T., Åkerblom, A., Ghukasyan, T. et al. (11 more authors) (2018) Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial. Journal of the American Heart Association, 7 (2). e007009.

Lowenstern, A., Storey, R.F. orcid.org/0000-0002-6677-6229, Neely, M. et al. (12 more authors) (2017) Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndrome. Journal of Thrombosis and Thrombolysis, 44 (2). pp. 145-153. ISSN 0929-5305

Lindholm, D., Hagström, E., James, S.K. et al. (10 more authors) (2017) Growth differentiation factor 15 at 1 month after an acute coronary syndrome is associated with increased risk of major bleeding. Journal of the American Heart Association, 6 (4). ISSN 2047-9980

Andell, P., James, S.K., Cannon, C.P. et al. (10 more authors) (2015) Ticagrelor versus clopidogrel in patients with acute coronary syndromes and chronic obstructive pulmonary disease: An analysis from the platelet inhibition and patient outcomes (PLATO) trial. Journal of the American Heart Association, 4 (10). e002490. ISSN 2047-9980

Proceedings Paper

Sumaya, W., Wallentin, L., James, S.K. et al. (6 more authors) (2018) Adverse fibrin clot properties are associated with worse outcome following acute coronary syndrome: a PLATO substudy. In: Circulation. American Heart Association's 2017 Scientific Sessions and Resuscitation Science Symposium, 11-15 Nov 2017, Anaheim, California. American Heart Association .